856
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Predictions instead of panics: the framework and utility of systematic forecasting of novel psychoactive drug trends

, PhD
Pages 519-526 | Received 09 Sep 2014, Accepted 09 Dec 2014, Published online: 16 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Kostas Skliamis & Giorgos Chatzinakos. (2023) ‘It’s a magical weed’: an exploration of drug-themed chants in Greek football fandom. Sport in Society 26:10, pages 1627-1646.
Read now
Charles Veltri & Oliver Grundmann. (2019) Current perspectives on the impact of Kratom use. Substance Abuse and Rehabilitation 10, pages 23-31.
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Jo Ann LeQuang, Robert Taylor$suffix/text()$suffix/text() & Robert B. Raffa. (2018) Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin. Postgraduate Medicine 130:1, pages 1-8.
Read now
David A. Gorelick & Sterling McPherson. (2015) Improving the analysis and modeling of substance use. The American Journal of Drug and Alcohol Abuse 41:6, pages 475-478.
Read now

Articles from other publishers (10)

Cinzia Citti, Aldo Laganà, Anna Laura Capriotti, Carmela Maria Montone & Giuseppe Cannazza. (2023) Kratom: The analytical challenge of an emerging herbal drug. Journal of Chromatography A 1703, pages 464094.
Crossref
Damien Rhumorbarbe, Marie Morelato, Ludovic Staehli, Claude Roux, David-Olivier Jaquet-Chiffelle, Quentin Rossy & Pierre Esseiva. (2019) Monitoring new psychoactive substances: Exploring the contribution of an online discussion forum. International Journal of Drug Policy 73, pages 273-280.
Crossref
Scott E. Hemby, Scot McIntosh, Francisco Leon, Stephen J. Cutler & Christopher R. McCurdy. (2019) Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine . Addiction Biology 24:5, pages 874-885.
Crossref
Andres Avellaneda-Ojeda, Syed Murtaza, Asim A. Shah & Nidal Moukaddam. (2018) Stimulant Use Disorders. Psychiatric Annals 48:8, pages 372-378.
Crossref
Luther Elliott, Ellen Benoit, Stephanie Campos & Eloise Dunlap. (2018) The long tail of a demon drug: The ‘bath salts’ risk environment. International Journal of Drug Policy 51, pages 111-116.
Crossref
Justin Poklis, Alphonse Poklis, Carl Wolf, Cindie Hathaway, Elise Arbefeville, Leszek Chrostowski, Kelly Devers, Laura Hair, Mary Mainland, Michele Merves & Julia Pearson. (2016) Two Fatal Intoxications Involving Butyryl Fentanyl. Journal of Analytical Toxicology 40:8, pages 703-708.
Crossref
Maria Katselou, Ioannis Papoutsis, Panagiota Nikolaou, Chara Spiliopoulou & Sotiris Athanaselis. (2016) Old opioids, new concerns: the case of acetylfentanyl. Forensic Toxicology 34:2, pages 201-212.
Crossref
John Stogner, Julie Baldwin, Timothy Brown & Taylor Chick. (2015) Perceptions of Powdered Alcohol and Intentions to Use: An Exploratory Qualitative Assessment of Potential Palcohol Use by Young Adults. Beverages 1:4, pages 329-340.
Crossref
Justin Poklis, Alphonse Poklis, Carl Wolf, Mary Mainland, Laura Hair, Kelly Devers, Leszek Chrostowski, Elise Arbefeville, Michele Merves & Julia Pearson. (2015) Postmortem tissue distribution of acetyl fentanyl, fentanyl and their respective nor-metabolites analyzed by ultrahigh performance liquid chromatography with tandem mass spectrometry. Forensic Science International 257, pages 435-441.
Crossref
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, Darshan Singh, Zsolt Demetrovics, Andres Roman-Urrestarazu, Francesco Saverio Bersani, Balasingam Vicknasingam, Giulia Piazzon, Jih-Heng Li, Wen-Jing Yu, Máté Kapitány-Fövény, Judit Farkas, Massimo Di Giannantonio & Ornella Corazza. (2015) Following “the Roots” of Kratom ( Mitragyna speciosa ): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries . BioMed Research International 2015, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.